EICHORCondition: Metastatic Castration-resistant Prostate Cancer · Sponsor: BioNTech SE
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study will test whether BNT324 is safe and works better against metastatic castration-resistant prostate cancer (mCRPC) than the current standard of care (SoC) chemotherapy, which is docetaxel (given together with the steroid medicines prednisone or prednisolone). The study will include participants with mCRPC that have been previously treated with androgen receptor pathway inhibitor, but with no previous taxane-based systematic chemotherapy for mCRPC. The main goals of this study are: * To find out if BNT324 helps participants live longer without their cancer getting worse (radiographic progression-free survival \[rPFS\]). * To find out if BNT324 helps participants live longer overall (overall survival \[OS\]).
This description comes directly from the study's public registry record.
BioNTech clinical trials patient information · +49 6131 9084 · patients@biontech.de
Always discuss trial participation with your own doctor first.
| Rocky Mountain Cancer Centers | Aurora, Colorado, United States | Recruiting |
| Florida Cancer Specialists- Fort Myers | Fort Myers, Florida, United States | Recruiting |
| Florida Cancer Specialists- St. Petersburg | St. Petersburg, Florida, United States | Recruiting |
| Florida Cancer Specialists- West Palm Beach | West Palm Beach, Florida, United States | Recruiting |
| Illinois Cancer Specialists | Niles, Illinois, United States | Recruiting |
| Illinois CancerCare PC | Peoria, Illinois, United States | Recruiting |
| Maryland Oncology Hematology | Rockville, Maryland, United States | Recruiting |
| Oncology/Hematology Care, Inc. | Cincinnati, Ohio, United States | Recruiting |
| SCRI Oncology Partners | Nashville, Tennessee, United States | Recruiting |
| Texas Oncology South Austin | Austin, Texas, United States | Recruiting |
| Texas Oncology Gulf Coast | Houston, Texas, United States | Recruiting |
| Texas Oncology, P.A. - Tyler | Tyler, Texas, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07365995